# KPV dosage & reconstitution (10 mg vial)

KPV dosage: calculations for a 10 mg vial use the same amounts described in the literature. Adding 2 mL of bacteriostatic water produces 5 mg/mL, so each U-100 unit contains 50 mcg.

- **Vial contents:** 10 mg KPV
- **Final volume:** 2 mL
- **Concentration:** 5 mg/mL
- **One U-100 unit:** 50 mcg in 0.01 mL

## Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing

### Standard / Gradual Approach (2 mL = ~5 mg/mL)

| Week / phase | Daily dose | Units per injection (mL) |
|---|---|---|
| Week 1 | 200 mcg | 4 units (0.04 mL) |
| Week 2 | 300 mcg | 6 units (0.06 mL) |
| Week 3 | 400 mcg | 8 units (0.08 mL) |
| Weeks 4–8 | 500 mcg | 10 units (0.10 mL) |

Frequency: Once daily, subcutaneously, at a consistent time.

### Reconstitution Steps

1. Draw 2 mL of bacteriostatic water with a sterile syringe.
2. Inject slowly down the vial wall; avoid shaking to prevent foaming.
3. Gently swirl or roll until fully dissolved (clear solution).
4. Label with the reconstitution date and refrigerate at 2–8 °C, protected from light; use within 4 weeks.

Important: this guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

## U-100 Conversion Table

| U-100 units | Volume | Contains | Yield per vial |
|---|---|---|---|
| 2 | 0.02 mL | 100 mcg | 100 injections |
| 5 | 0.05 mL | 250 mcg | 40 injections |
| 10 | 0.10 mL | 500 mcg | 20 injections |
| 20 | 0.20 mL | 1 mg (1000 mcg) | 10 injections |
| 30 | 0.30 mL | 1.5 mg (1500 mcg) | 6 injections |
| 50 | 0.50 mL | 2.5 mg (2500 mcg) | 4 injections |
| 100 | 1.00 mL | 5 mg (5000 mcg) | 2 injections |

## Supplies Needed

**KPV vials (10 mg each)**
- Standard / Gradual Approach, 12 weeks: Minimum 4 vials (37.8 mg required).
- Standard / Gradual Approach, 24 weeks: Minimum 8 vials (79.8 mg required).

**U-100 syringes (1 mL)**
- Standard / Gradual Approach, 12 weeks: 84 new syringes for 84 injections.
- Standard / Gradual Approach, 24 weeks: 168 new syringes for 168 injections.

**Bacteriostatic water**
- Standard / Gradual Approach, 12 weeks: 8 mL total (2 mL per vial) → 3 × 3 mL vials.
- Standard / Gradual Approach, 24 weeks: 16 mL total (2 mL per vial) → 6 × 3 mL vials.

**Alcohol swabs**
- Standard / Gradual Approach, 12 weeks: 168 minimum; one box of 100 does not cover the calculation.
- Standard / Gradual Approach, 24 weeks: 336 minimum; one box of 100 does not cover the calculation.

## Storage Instructions

- Lyophilized (unopened): −20 °C for long-term storage; 2–8 °C if used within weeks. Protected from light.
- Reconstituted: 2–8 °C, do not freeze. Use within the documented period (typically up to 4 weeks with bacteriostatic water).
- Handling: do not shake; avoid temperature cycling; label with date and concentration.
- Discard: cloudy solutions, particulates or expired preparations are discarded.

## How This Works

KPV exerts its action through multiple anti-inflammatory pathways: NF-κB Inhibition blocks nuclear translocation of the master transcription factor of inflammation, reducing the production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). Macrophage modulation induce polarization towards the M2 (anti-inflammatory and reparative) phenotype and reduces the M1 phenotype. Action on intestinal epithelial cells: improves intestinal barrier integrity, reduces permeability, and promotes epithelial regeneration. Melanocortin receptor activation preferentially binds to MC1R with lower affinity than α-MSH, which reduces pigmentary effects.

## References

1. Brzoska T, Luger TA, Maaser C, et al. α-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo. Endocr Rev. 2008;29(5):581-602.
2. Kannengiesser K, Maaser C, Heidemann J, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(3):324-331.
3. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178.

---
Source: https://protocolopeptidos.com/en/compuestos/kpv-10mg · Important: this guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.